Kilo.

Kilo.

Tirzepatide

Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first compound to simultaneously target both incretin receptor pathways. GIP
receptor agonism contributes adipose tissue-level effects on lipid storage and insulin sensitivity, augmenting the established metabolic
effects of GLP-1 agonism alone. Published Phase 3 SURPASS trial data (NEJM 2022) demonstrated approximately 20% body weight
reduction — significantly greater than single GLP-1 agonists. Available in 10mg, 15mg, and 30mg vials to support a range of research
protocols from standard dose-response studies to extended multi-arm designs

GLP-1 + GIP Dual Agonist Lyophilized 99%+ Purity COA Included

5.0 Reviews

Price range: $75.00 through $185.00

2 Day FAST Shipping

99%+ Purity Tests

Ships from USA

We accept :

Kilo.

Follow Us
Linkedin X-twitter Icon-instagram-1 Facebook-square
Research — Kiloresearch.com

Research Use Verification Required

⚠ Important Notice

All products sold on kiloresearch.com are strictly for laboratory and research use only. NOT for human or animal consumption, self-administration, or any therapeutic purpose.

Products are intended solely for scientific investigation by qualified professionals. Not approved by the FDA for human use.

By accessing this website, you confirm that you understand and accept all associated risks, and that you are purchasing solely for lawful research purposes.

Kilo Research bears no liability for misuse of its products.
By entering you confirm you have read and agreed to all terms above.